Abstract
The durability of protective humoral immunity after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and infection is largely dependent on the generation and persistence of antigen-specific isotype-switched memory B cells (MBCs) and long-lived plasma cells that reside in the bone marrow and secrete high-affinity neutralizing antibodies. The reactivity of vaccine-induced MBCs to emerging clinically significant SARS-CoV-2 variants of concern (VoCs) is largely unknown. In a longitudinal cohort study (up to 6 months following coronavirus disease 2019 messenger RNA vaccination), we measured MBCs in concert with other functional antibody measures. We found statistically significant differences between the frequencies of MBCs responding to homologous and VoC (Beta, Gamma, and Delta) receptor-binding domains after vaccination that persisted over time. In concert with a waning antibody response, the reduced MBC response to VoCs could translate to a weaker subsequent recall immune response and increased susceptibility to the emerging SARS-CoV-2 variant strains after vaccination.
Original language | English (US) |
---|---|
Pages (from-to) | 23-31 |
Number of pages | 9 |
Journal | Journal of Infectious Diseases |
Volume | 226 |
Issue number | 1 |
DOIs | |
State | Published - Jul 1 2022 |
Keywords
- B cells
- COVID-19
- SARS-CoV-2
- antibodies, neutralizing
- humoral immune responses
- immunological memory
- vaccine
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases